News Breaks |
|
|
| December 28, 2012 |
| 07:34 EDT |  | CPHD | Cepheid 2013 sales of CT/NG estimated $15M-$20M at William Blair
William Blair expects solid initial demand for Cepheid's just approved Xpert CT/NG from existing Xpert customers and projects 2013 sales between $15M-$20M on a worldwide basis. However, William Blair says it is not sure if Cepheid will be able to ship enough product to meet initial demand as it provided no update on the recent manufacturing issues. The firm keeps an Outperform rating on the stock. |
|
|
News For CPHD From The Last 14 Days Check below for free stories on CPHD the last two weeks. |
|
|
| There are no results for CPHD |
|
|
|
|
